About the study.
Investigational genetic testing can be done to see if you were born with the variation in your APOL1 gene that can increase the risk and progression of FSGS. The study will require blood and saliva samples to determine if you have this gene variation. The results of this investigational genetic test may qualify you for a future clinical research study for adults with FSGS.
The test used to determine if you have an APOL1 gene variation is not approved by the Food and Drug Administration (FDA) in the United States or any health authorities in other countries. This means that it is not available outside a research study and is not intended to drive decisions about your medical care. If you would like more information about this investigational genetic test, please ask the study doctor.
We are currently enrolling adults 18 years and older who have been diagnosed with biopsy-confirmed FSGS to take part in this clinical research study. It may be appropriate for those who meet the following criteria:
- Male or female of African, Caribbean, or Central or South American descent
- Are 18 years of age or older
- Diagnosed with FSGS via a previously done kidney biopsy
- Willing and able to comply with the testing requirements
Those who qualify will receive this investigational genetic testing at no cost. If you qualify, you may be compensated for your study-related time and reimbursed for travel.